hyperlipidemic type 2 diabetes mellitus patients. Diabetes mellitus
Conditions
Interventions
Intervention 1: group receiving turmeric:capsules containing 800mg turmeric, three a day for 8 weeks. Intervention 2: placebo group receiving :capsules containing 800mg of corn starch, three a day for
Treatment - Drugs
Placebo
group receiving turmeric:capsules containing 800mg turmeric, three a day for 8 weeks
placebo group receiving :capsules containing 800mg of corn starch, three a day for 8 weeks
Sponsors
Tehran university of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Willingness to participate in the study; People with type 2 diabetes; Aged people with 30 to 70 years of age; Aged people with 30 to 70 years of age; People having HbA1c above 6; Patients with TG>150mg/dl, LDL above 100mg/dl; Lack of consumption of multivitamin; supplements, antioxidants, polyphenols, since last three months; BMI 20 – 35 . Exclusion criteria of the study: Participants of the study under treatment had no changes in consumption of medicine; Patients having fasting blood glucose >200mg/dl or LDL>160mg/dl were excluded from the study; Changes in dose and type of medication; Inclusion criteria for the study: Acute cardiac disease, renal failure, liver and thyroid disease; Rejection of turmeric powder supplement. actation or pregnancy; Severe gastrointestinal disease and gastric ulcers; Risk of gall stones Changes in physical activity and diet;
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic blood pressure. Timepoint: 8 weeks. Method of measurement: sphygmomanometer.;Diastolic blood pressure. Timepoint: 8 weeks. Method of measurement: sphygmomanometer.;FBS. Timepoint: 8 week. Method of measurement: Laboratory kit.;Fasting Insulin. Timepoint: 8 week. Method of measurement: Laboratory kit.;HbA1C. Timepoint: 8 weeks. Method of measurement: Laboratory kit.;Triglyceride (TG). Timepoint: 8 weeks. Method of measurement: Laboratory kit.;Total Cholesterol (TC). Timepoint: 8 weeks. Method of measurement: Laboratory kit.;LDL. Timepoint: 8 weeks. Method of measurement: Laboratory Kit.;HDL. Timepoint: 8 weeks. Method of measurement: Laboratory Kit.;Apo A-I. Timepoint: 8 weeks. Method of measurement: Laboratory Kit.;Apo B-100. Timepoint: 8 weeks. Method of measurement: Laboratory kit.;CRP. Timepoint: 8 weeks. Method of measurement: Laboratory kit.;TAC. Timepoint: 8 weeks. Method of measurement: Laboratory kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZohreh Adab
school of health tehran university of medicalSciences
Outcome results
None listed